[Fraud in cancer studies. More stringent control required. The risk of fraud is increased by commercialization].
Werkö
L
L
D001943:Breast Neoplasms / Q000601:surgery*; D002986:Clinical Trials as Topic / Q000592:standards*; D005260:Female; D006801:Humans; D015871:Scientific Misconduct; D006113:United Kingdom; D014481:United States
Fusk i studie om cancer. Skärpta krav på kontroll. Kommersialisering ökar risken för fusk.